Peer Review History
| Original SubmissionAugust 17, 2020 |
|---|
|
PONE-D-20-25714 Correlation among sitting balance, trunk control, mobility, and activities daily living, and predictive validity of mobility level in survivors with sub-acute stroke PLOS ONE Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address the objections raised by reviewer 2 especially concerning the better explanation of the rationale and the study design. Consider also all the other minor points. Please submit your revised manuscript by November 20th. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Andrea Martinuzzi Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please address the following: - Please refer to any sample size calculations performed prior to participant recruitment. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). - Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. During your revisions, please note that a simple title correction is required to ensure no errors of grammar: "Correlation between sitting balance, trunk control, mobility and daily living activities with predictive validity of mobility level in survivors of sub-acute stroke". Please ensure this is updated in the manuscript file and the online submission information. 4.Thank you for stating the following financial disclosure: [No.]. At this time, please address the following queries:
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5.Thank you for stating the following in your Competing Interests section: [No.]. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 6.Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files 7. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: a. Question 1 → Although the work is very interesting and sound, the introduction is not completely linear and not adequately developed to soundly understand the work. b. Question 1 → Please, at pag. 9 row 29-30, specify in a more detailed way the aim of the study. c. Question 4 → Even if the article is totally written in plain and sound English, at pag. 13 rows from 6 to 9, the specific phrase needs to be better explained. d. Please, at pag. 8 row 10, correct the initial “zero” number as written on all other decimal values in the list. e. Even if the statistical approach seems sound, at pag. 19, the two groups identified as: “Mobility available group” and “Mobility impaired group” seems to be too much different in population number (41 / 14). f. Even if it has been declared that age is not a fundamental factor, it seems that all the subject population are young. Reviewer #2: Review_PONE-D-20-25714 Major comments #1. What is the significance of using trunk/sitting balance performance to predict mobility? Please explain in the introduction. While trunk performance and/or sitting balance are important to mobility from previous research, I don’t think that as a reason to exclude other factors (e.g. lower extremity strength). What does reporting moderate predictive validity as a result of limited predictors lead to? Please also highlight the significance of this entire study in the introduction. #2. Most importantly, I don’t see the clinical significance of predicting current TUG in a patient with measurable TUG. What is important is not predicting TUG, but that the mobility to be assessed by TUG can be explained a lot by sitting balance? 3. The two objectives seem to create confusion. What you want to clarify is the correlation between TUG and other performance test? Or is it trunk/sitting performance as a predictor of TUG? The conclusions do not seem to emphasize the correlation. 4. Although your study is a cross-sectional design, there are several representations that can be used to predict future mobility. Please give appropriate consideration to the information available from the results. 5. What is the significance or hypothesis of the MBI that was evaluated? Do you just want to investigate the correlation to TUG? ADLs were discussed in the previous studies presented in the introduction, but they were not mentioned in the DISCUSSION. Minor comments overall #1. In the title, aim, and abstract, you use “among sitting balance, trunk control, mobility, and activities daily living" and "between sitting balance, trunk control, mobility and ADL”, it's hard to understand what you want to compare them to. The results only show an correlation between mobility and other factors. This can lead to a misunderstanding and a misguided purpose, as if it investigated a correlation among all factors. #2. The key word was “chronic stroke”, is that correct? abstract #3. P2, L2. Is it gait ability or mobility that you predict? If you don't distinguish and define it, then please unify. #4. P2, L10. Is the Finding notation TCT (r = -0.65)? There should be a space before and after “=”. #5. P2, L11-14. Please indicate what the ROC curve or AUC is intended to do. to predict mobility? #6. P2, L17. “...predicting the improvement of mobility after stroke.” does not prove improvement from this cross-sectional design. Introduction #7. P3, L10-30. The introduction as a whole hypothesizes the usefulness of SBS and these indicators as tools that can predict ADLs. Nevertheless, as a purpose, SBS is not the subject matter and what it predicts is not ADL. So, It’s hard to understand the flow of why you want to predict mobility. The connection from background to purpose seems somewhat forced. Please clarify the hypothesis and revise the structure. #8. P2, L1-5. The use of the sitting balance tools scarce and BBS is explained at the beginning of the Introduction, but in the context of the “overall, SBS, Trunk Impairment Scale…(P3, L14-16)” there are other assessments that can be measured in the supine and sitting positions besides the SBS, Please explain these discrepancies. #9. With regard to trunk control and sitting balance used in various contexts, it is often difficult to separate them. For example, the TCT and TIS also include sitting balance as an entry. Are there any definitions used in this study and any differences between there two elements? Methods #10. P4, L1-2. There is no mention of walking ability in the subject recruitment, is there a standard? At this time of year, I don't think everyone is capable of TUG. Or should readers understand that only those who are able to walk on advertisement have applied? #11. P4, L3-4. Related to the above, what are the reasons for drop-outs in cross-sectional studies? Does this mean that there was a request from the patient, but it took a long time for the actual measurement to be taken, resulting in health deterioration and discharge? #12. P4, L2. What is your rationale for using MMSE > 23 as the inclusion criteria? Does it appear that cognitive ability has a significant impact on the content of this assessment? #13. P4, L13. Can you indicate the extent of “...experience in using these tools”? It seems ambiguous. #14. P4, L20-24. Please indicate the original citation for the TUG at the beginning of the description of the TUG (Reference No. 14). In addition, please describe the speed conditions of the TUG. #15. P4, L28-30. Please reiterate the reference of SBS reliability. #16. P5, L12-13. Please reiterate the reference of TCT validity. #17. P5, 34-35. What was the reason for comparing the two groups using only the Chi-square test after confirming the normal distribution in the statistical analysis? Results #18. P6, L20. SBS and TIS have similar numbers in the results. What are the correlation coefficients between these two variables? Discussion also states that it is very closely related [2]. Even though the concepts are different, we get the impression that the content of the test is also partially common. It is recommended to emphasize the concept and relationship between the two variables in the introduction or discussion. Discussion #19. P6, L29-30. “The results of the present study...had significantly reduced mobility (TUG),” is natural because it generates two groups according to TUG. It is an unnecessary expression. #20. P6, L29-34. Several repetitions of the results are described. Please summarize (especially the numbers) and organize them. #21. P7, L11-13. The sentence of “Specifically, the stroke suvivors ... may not be included.”, what is your rationale for describing the inappropriate compensatory strategy and use assistive device? The authors don't consider the assistive device in recruitment and allow it to be used in the TUG, but what was the device usage rate? #22. P7, L15-18. What do the authors mean by “However, in this study, ... postural control and mobility." It is somewhat difficult to understand the implications of these sentences. Is there any evidence to be drawn from the results of this context or from previous studies?” #23. P7, L19-23. The sentence of “The TCT and ... for TIS, respectively)”, this is the kind of sentence is a repetition of the results, or it should be written in the Results section. #24. P7, L19. Please state the rationales or add a citation for “the TCT and PASS-TC are suitable for use in acute and subacute patients.” #25. P7, L23-25. There is a lack of textual basis or citation for “In addition, the balance…required to perform the TUG.” #26. P8, L4-6. What do these citations explain about “Medley et al and …examination of TIS [15, 18]”? Since SBS and TIS are newer reports than these articles, please clarify what you mean by these citations. Also, what do you mean by “in SBS, which is traditionally used,” in the sentence that follows? #27. Please make the Limitation clear. As I see it, there are several limitations. Table 1. #28. What is the meaning of †? #29. The percentages of the paralysis location are not shown. Table 3. #30. * does not appear to be in the table. Please remove it. #31. Is this table showing a cut-off score to predict the mobility available group? I hope that my comment is very useful for the improvement of the article. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-25714R1 Correlation between sitting balance, trunk control, mobility and daily living activities with predictive validity of mobility level in survivors of sub-acute stroke PLOS ONE Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. There are stil comments from the reviewwer 2 that require your attention and need to be addressed properly Please submit your revised manuscript by march 31st. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Andrea Martinuzzi Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Review_PONE-D-20-25714 I have checked your revised manuscript, but there are still some things that you cannot responded. Please refer to the following comments to improve your manuscript. Major comments #1. What is the significance of using trunk/sitting balance performance to predict mobility? The significance/necessity of this study has not been demonstrated. The introduction is still not clear and linear. Please clarify the following: ・What is the significance of targeting the sub-acute phase? ・The purpose is not clear. Make it clear whether you want to see relationships or predict mobility. The latter seems to be written like a main message, but if so, it needs to be explicit in the introduction (TUG is the subject in the Findings). ・Please state your research hypothesis. If you want to reveal scale properties in an exploratory manner, please insist on doing so. I don’t understand why mobility is suddenly mentioned at the end of Introduction. #2. Again, you will also need to answer the following question. “Most importantly, I don’t see the clinical significance of predicting current TUG in a patient with measurable TUG. What is important is not predicting TUG, but that the mobility to be assessed by TUG can be explained a lot by sitting balance?” Previous studies have proposed the importance of trunk/sitting balance performance to predict future TUG (not the current TUG). #3. Related to the above, the overall structure of the introduction section could be further improved. The introduction flow sounds like it emphasizes the advantage of SBS, but is doesn’t seem to be connected to the hypothesis or purpose. Isn’t the flow that SBS is supposed to reflect TUG more than TCT, TIS, or PASS-TC? If you want to emphasize SBS, the significance of the description of BBS and FRT before it appears to be unimportant. Is SBS an alternative to BBS and FRT? It might be more appropriate to emphasize mobility first instead. For example. 1. General remarks: stroke and their balance and gait ability 2. Mobility: the significance and necessity of predicting mobility 3. Current status of indices proposed for this purpose 4. Validity of the SBS 5. Hypothesis and purpose In particular, “2. Mobility“ is important because they determine the significance of this study. Again, is there a need to bother predicting the current TUG? If you change the introduction, please reorganize the discussion with the corresponding text. Minor comments #4. Title It may need to be modified to meet the purpose of the text. Consider whether it is appropriate to use the term "predictive" for current mobility. For example, it might be as simple as "the relationship between trunk/sitting balance performance and mobility". #5. Abstract Your purpose is the same as the title. Isn't the main message to identify what can predict mobility level? What is the significance of looking at the relationship between clinical indicators? Is there a specific reason to focus on the sub-acute phase? If not, this information should be in Methods. Methods: The sample size of 65 participants in methods is misleading, and the actual number of participants (55) needs to be indicated. There is no information at all to process the predictions. It is just a list of scales, but it is not a research method. Findings: Isn't ROC to “predict the TUG”? Results about predictions are not describe in the methods. Please standardize the notation of 0 ( .84 or -0.78). Conclusion: “Sub-acute stroke survivors” is repeated in the Conclusion. Other redundant expressions are also noticeable #6. Introduction You describe the relationship between each indicator, but I don't understand what you are trying to explain. Is the purpose of your research to verify the validity of the scale? It is not appropriate to say that you examined the relationship because it is unknown. Please discuss what you are trying to say by examining the relationship. #7. Introduction What does the percentages in the relationship sentences in TIS and TCT stand for? #8. Introduction Please do not abbreviate the BI of the first appearance. #9. Discussion The discussion is redundant (e.g., repetition of the same terms, repetition of the same kind of arguments). Please organize your arguments. #10. Discussion Regarding the sentence "For the first time, we presented a selection criterion for predicting mobility level", as pointed out in the intro, I did not understand the need to show the predicted TUG for those who are capable of TUG using other indicators. Please include this reason and emphasize it again in your discussion. Otherwise, the significance of the study shown “for the first time” will not be conveyed. #11. Discussion “It's a mobility available group that can walk and if the time to perform a TUG test is equal or less than 20 seconds, it's a mobility impaired group that can't walk”. What is the point you are trying to make with these related sentences? Is it a repetition of the methodology? #12. Conclusion The conclusion does not receive your purpose. The objective to lead this conclusion is “does the sitting balance correlate with current mobility?” I'm not sure if “prediction” is the right term, but it is common for linear prediction to hold if there is a correlation. Isn't the basic argument and conclusion not the validity of the predictions, but how the sitting balance relates to mobility? If you want to argue for predictive validity, I think the title and purpose should reflect “the validity of the sitting balance that predicts the current TUG”. If the latter, sitting balance is highly correlated with mobility, so it is important to focus on sitting balance in sub-acute stroke. Additional comment There are sentences that need to be consistent with the time period as a whole. In particular, the report of previous studies should be shown in the past tense. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
PONE-D-20-25714R2 The relationship between sitting balance, trunk control and mobility with predictive for current mobility level in survivors of sub-acute stroke PLOS ONE Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address the remaining suggestion of reviewer 2 Please submit your revised manuscript by May 10th. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Andrea Martinuzzi Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Abstract Is this sufficient to describe the Methods? It doesn't seem to correspond to Finding section. The following is my previous comment. I will present this again. Findings: Isn't ROC to “predict the TUG”? Results about predictions are not describe in the methods. Please standardize the notation of 0 ( .84 or -0.78). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
The relationship between sitting balance, trunk control and mobility with predictive for current mobility level in survivors of sub-acute stroke PONE-D-20-25714R3 Dear Dr. Lee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Andrea Martinuzzi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-25714R3 The relationship between sitting balance, trunk control and mobility with predictive for current mobility level in survivors of sub-acute stroke Dear Dr. Lee: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Andrea Martinuzzi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .